These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 22941121)

  • 1. Towards excellence in revascularization for left main coronary artery disease.
    Osnabrugge RL; Head SJ; Bogers AJ; Kappetein AP
    Curr Opin Cardiol; 2012 Nov; 27(6):604-10. PubMed ID: 22941121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term forecasting and comparison of mortality in the Evaluation of the Xience Everolimus Eluting Stent vs. Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization (EXCEL) trial: prospective validation of the SYNTAX Score II.
    Campos CM; van Klaveren D; Farooq V; Simonton CA; Kappetein AP; Sabik JF; Steyerberg EW; Stone GW; Serruys PW;
    Eur Heart J; 2015 May; 36(20):1231-41. PubMed ID: 25583761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Left Main Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Patients With Prior Cerebrovascular Disease: Results From the EXCEL Trial.
    Diamond J; Madhavan MV; Sabik JF; Serruys PW; Kappetein AP; Leon MB; Taggart DP; Berland J; Morice MC; Gersh BJ; Kandzari DE; Dressler O; Stone GW
    JACC Cardiovasc Interv; 2018 Dec; 11(24):2441-2450. PubMed ID: 30573053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality-of-Life After Everolimus-Eluting Stents or Bypass Surgery for Left-Main Disease: Results From the EXCEL Trial.
    Baron SJ; Chinnakondepalli K; Magnuson EA; Kandzari DE; Puskas JD; Ben-Yehuda O; van Es GA; Taggart DP; Morice MC; Lembo NJ; Brown WM; Banning A; Simonton CA; Kappetein AP; Sabik JF; Serruys PW; Stone GW; Cohen DJ;
    J Am Coll Cardiol; 2017 Dec; 70(25):3113-3122. PubMed ID: 29097293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mortality After Repeat Revascularization Following PCI or CABG for Left Main Disease: The EXCEL Trial.
    Giustino G; Serruys PW; Sabik JF; Mehran R; Maehara A; Puskas JD; Simonton CA; Lembo NJ; Kandzari DE; Morice MC; Taggart DP; Gershlick AH; Ragosta M; Kron IL; Liu Y; Zhang Z; McAndrew T; Dressler O; Généreux P; Ben-Yehuda O; Pocock SJ; Kappetein AP; Stone GW
    JACC Cardiovasc Interv; 2020 Feb; 13(3):375-387. PubMed ID: 31954680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term outcomes after stenting versus coronary artery bypass grafting for unprotected left main coronary artery disease: 10-year results of bare-metal stents and 5-year results of drug-eluting stents from the ASAN-MAIN (ASAN Medical Center-Left MAIN Revascularization) Registry.
    Park DW; Kim YH; Yun SC; Lee JY; Kim WJ; Kang SJ; Lee SW; Lee CW; Kim JJ; Choo SJ; Chung CH; Lee JW; Park SW; Park SJ
    J Am Coll Cardiol; 2010 Oct; 56(17):1366-75. PubMed ID: 20946993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and rationale for a randomised comparison of everolimus-eluting stents and coronary artery bypass graft surgery in selected patients with left main coronary artery disease: the EXCEL trial.
    Kappetein AP; Serruys PW; Sabik JF; Leon MB; Taggart DP; Morice MC; Gersh BJ; Pocock SJ; Cohen DJ; Wallentin L; Ben-Yehuda O; van Es GA; Simonton CA; Stone GW
    EuroIntervention; 2016 Sep; 12(7):861-72. PubMed ID: 27639738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Revascularization of unprotected left main coronary artery disease: strategy selection and systematic risk assessment.
    Palmerini T; Alessi L; Dangas G
    Catheter Cardiovasc Interv; 2012 Aug; 80(2):199-205. PubMed ID: 22511269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coronary artery bypass grafting versus drug-eluting stent implantation for left main coronary artery disease (from a two-center registry).
    Kang SH; Park KH; Choi DJ; Park KW; Chung WY; Lim C; Kim KB; Kim HS
    Am J Cardiol; 2010 Feb; 105(3):343-51. PubMed ID: 20102946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bypass Surgery or Stenting for Left Main Coronary Artery Disease in Patients With Diabetes.
    Milojevic M; Serruys PW; Sabik JF; Kandzari DE; Schampaert E; van Boven AJ; Horkay F; Ungi I; Mansour S; Banning AP; Taggart DP; Sabaté M; Gershlick AH; Bochenek A; Pomar J; Lembo NJ; Noiseux N; Puskas JD; Crowley A; Kosmidou I; Mehran R; Ben-Yehuda O; Généreux P; Pocock SJ; Simonton CA; Stone GW; Kappetein AP
    J Am Coll Cardiol; 2019 Apr; 73(13):1616-1628. PubMed ID: 30947913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical myocardial revascularization versus percutaneous coronary intervention with drug-eluting stents in octogenarian patients.
    Ben-Gal Y; Finkelstein A; Banai S; Medalion B; Weisz G; Genereux P; Moshe S; Pevni D; Aviram G; Uretzky G
    Heart Surg Forum; 2012 Aug; 15(4):E204-9. PubMed ID: 22917825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of coronary artery bypass grafting versus percutaneous coronary intervention with drug-eluting stents for patients with multivessel coronary artery disease.
    Javaid A; Steinberg DH; Buch AN; Corso PJ; Boyce SW; Pinto Slottow TL; Roy PK; Hill P; Okabe T; Torguson R; Smith KA; Xue Z; Gevorkian N; Suddath WO; Kent KM; Satler LF; Pichard AD; Waksman R
    Circulation; 2007 Sep; 116(11 Suppl):I200-6. PubMed ID: 17846304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of one-year outcomes of percutaneous coronary intervention versus coronary artery bypass grafting in patients with unprotected left main coronary artery disease and acute coronary syndromes (from the CUSTOMIZE Registry).
    Caggegi A; Capodanno D; Capranzano P; Chisari A; Ministeri M; Mangiameli A; Ronsivalle G; Ricca G; Barrano G; Monaco S; Di Salvo ME; Tamburino C
    Am J Cardiol; 2011 Aug; 108(3):355-9. PubMed ID: 21545992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multivessel coronary revascularization in patients with and without diabetes mellitus: 3-year follow-up of the ARTS-II (Arterial Revascularization Therapies Study-Part II) trial.
    Daemen J; Kuck KH; Macaya C; LeGrand V; Vrolix M; Carrie D; Sheiban I; Suttorp MJ; Vranckx P; Rademaker T; Goedhart D; Schuijer M; Wittebols K; Macours N; Stoll HP; Serruys PW;
    J Am Coll Cardiol; 2008 Dec; 52(24):1957-67. PubMed ID: 19055986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New-Onset Atrial Fibrillation After PCI or CABG for Left Main Disease: The EXCEL Trial.
    Kosmidou I; Chen S; Kappetein AP; Serruys PW; Gersh BJ; Puskas JD; Kandzari DE; Taggart DP; Morice MC; Buszman PE; Bochenek A; Schampaert E; Pagé P; Sabik JF; McAndrew T; Redfors B; Ben-Yehuda O; Stone GW
    J Am Coll Cardiol; 2018 Feb; 71(7):739-748. PubMed ID: 29447735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two-year (mid-term) results for unprotected left main coronary artery percutaneous interventions with drug-eluting stents.
    Yarkoni A; Brodsky A; Sabapathy R; Pershad A
    Indian Heart J; 2008; 60(3):195-9. PubMed ID: 19240306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized comparison of percutaneous coronary intervention with coronary artery bypass grafting in diabetic patients. 1-year results of the CARDia (Coronary Artery Revascularization in Diabetes) trial.
    Kapur A; Hall RJ; Malik IS; Qureshi AC; Butts J; de Belder M; Baumbach A; Angelini G; de Belder A; Oldroyd KG; Flather M; Roughton M; Nihoyannopoulos P; Bagger JP; Morgan K; Beatt KJ
    J Am Coll Cardiol; 2010 Feb; 55(5):432-40. PubMed ID: 20117456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Percutaneous coronary intervention with drug-eluting stent versus coronary artery bypass grafting: A meta-analysis of patients with left main coronary artery disease.
    Spinthakis N; Farag M; Gorog DA; Prasad A; Mahmood H; Gue Y; Wellsted D; Nabhan A; Srinivasan M
    Int J Cardiol; 2017 Dec; 249():101-106. PubMed ID: 28958756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Revascularization of left main coronary artery disease.
    Lee MS; Faxon DP
    Cardiol Rev; 2011; 19(4):177-83. PubMed ID: 21646871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term safety and efficacy of percutaneous coronary intervention with stenting and coronary artery bypass surgery for multivessel coronary artery disease: a meta-analysis with 5-year patient-level data from the ARTS, ERACI-II, MASS-II, and SoS trials.
    Daemen J; Boersma E; Flather M; Booth J; Stables R; Rodriguez A; Rodriguez-Granillo G; Hueb WA; Lemos PA; Serruys PW
    Circulation; 2008 Sep; 118(11):1146-54. PubMed ID: 18725490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.